No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: A case-control study

Early Human Development

Volumn 85, Issue 4, 2009, Pages 253-257

  van Stralen, Giel ^a   van der Bos, Jetske ^a   Lopriore, Enrico ^a   te Pas, Arjan B ^a   Bloemenkamp, Kitty W M ^a   Walther, Frans J ^a   Scherjon, Sicco ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antenatal corticosteroid therapy; Chronic lung disease, IRDS; Intrauterine growth restriction; Neonatal outcome; Prematurity

Indexed keywords

CORTICOSTEROID;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BIRTH WEIGHT; BRAIN DAMAGE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DELIVERY; DISEASE SEVERITY; FEMALE; FETUS; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MIDDLE CEREBRAL ARTERY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; PRENATAL CARE; RETROSPECTIVE STUDY; UMBILICAL ARTERY;

ADRENAL CORTEX HORMONES; CASE-CONTROL STUDIES; COHORT STUDIES; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; RETROSPECTIVE STUDIES;

EID: 61849119070     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2008.10.010     Document Type: Article

References (52)

1. Liggins G.C., and Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50 (1972) 515-525
2. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 273 (1995) 413-418
3. Chien L.Y., Ohlsson A., Seshia M.M., Boulton J., Sankaran K., and Lee S.K. Variations in antenatal corticosteroid therapy: a persistent problem despite 30 years of evidence. Obstet Gynecol 99 (2002) 401-408
4. Papageorgiou A.N., Desgranges M.F., Masson M., Colle E., Shatz R., and Gelfand M.M. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics 63 (1979) 73-79
5. Morales W.J., Diebel N.D., Lazar A.J., and Zadrozny D. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes. Am J Obstet Gynecol 154 (1986) 591-595
6. Schutte M.F., Treffers P.E., Koppe J.G., and Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. Br J Obstet Gynaecol 87 (1980) 127-131
7. Gould J.B., Gluck L., and Kulovich M.V. The relationship between accelerated pulmonary maturity and accelerated neurological maturity in certain chronically stressed pregnancies. Am J Obstet Gynecol 127 (1977) 181-186
8. Gould B., Gluck L., and Kulovich M.V. The acceleration of neurological maturation in high stress pregnancy and its relation to fetal lung maturity. Pediatr Res 6 (1972) 335
9. Procianoy R.S., Garcia-Prats J.A., Adams J.M., Silver A., and Rudolph A.J. Hyaline membrane disease and intraventricular haemorrhage in small for gestational age infants. Arch Dis Child 55 (1980) 502-505
10. Fetal growth restriction. In: Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, Hankins GDV et al., editors. Williams Obstetrics. London: Appleton & Lange; 1997. p. 839-853.
11. Martinez A., and Simmons R. Abnormalities of fetal growth. In: Taeusch H.W., Ballard R.A., and Gleason C.A. (Eds). Avery's disease of the newborn (2005), Elsevier Saunders Inc., Philadelphia 32-41
12. Effects of antenatal dexamethasone administration in the infant: long-term follow-up. J Pediatr 1984;104:259-267.
13. MacArthur B.A., Howie R.N., Dezoete J.A., and Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 70 (1982) 99-105
14. Schmand B., Neuvel J., Smolders-De Haas H., Hoeks J., Treffers P.E., and Koppe J.G. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 86 (1990) 58-64
15. Smolders-De Haas H., Neuvel J., Schmand B., Treffers P.E., Koppe J.G., and Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year follow-up. Pediatrics 86 (1990) 65-70
16. Resnik R. A different side of the corticosteroid story. Am J Obstet Gynecol 190 (2004) 295
17. Barrington K.J. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 1 (2001) 1
18. Hadi H.A. Fetal cerebral maturation in hypertensive disorders of pregnancy. Obstet Gynecol 63 (1984) 214-219
19. Sabolek M., Herborg A., Schwarz J., and Storch A. Dexamethasone blocks astroglial differentiation from neural precursor cells. NeuroReport 17 (2006) 1719-1723
20. Hack M., Breslau N., Weissman B., Aram D., Klein N., and Borawski E. Effect of very low birth weight and subnormal head size on cognitive abilities at school age. N Engl J Med 325 (1991) 231-237
21. Scherjon S.A., Smolders-DeHaas H., Kok J.H., and Zondervan H.A. The "brain-sparing" effect: antenatal cerebral Doppler findings in relation to neurologic outcome in very preterm infants. Am J Obstet Gynecol 169 (1993) 169-175
22. NVOG. Perinatologie/hypertensieve aandoeningen (20-5-2005). http://www.nvog-documenten.nl/ http://www.nvog-documenten.nl/
23. Jobe A.H., and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 (2001) 1723-1729
24. Bell M.J., Ternberg J.L., Feigin R.D., Keating J.P., Marshall R., Barton L., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187 (1978) 1-7
25. Prepared by an international committee. An international classification of retinopathy of prematurity. Br J Ophthalmol 68 (1984) 690-697
26. te Pas A.B., and Walther F.J. A randomized, controlled trial of delivery-room respiratory management in very preterm infants. Pediatrics 120 (2007) 322-329
27. Karr J.M., Faix R.G., Pryce C.J.E., and Bhatt-Mehta V. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr 125 (1994) 117-122
28. Levene M.I. Measurement of the growth of the lateral ventricles in preterm infants with real-time ultrasound. Arch Dis Child 56 (1981) 900-904
29. de Vries L.S., Eken P., and Dubowitz L.M. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 49 (1992) 1-6
30. Schaap A.H., Wolf H., Bruinse H.W., de Leeuw R., Van I E., and Treffers P.E. Fetal distress due to placental insufficiency at 26 through 31 weeks: a comparison between an active and a more conservative management. Eur J Obstet Gynecol Reprod Biol 70 (1996) 61-68
31. Laatikainen T.J., Raisanen I.J., and Salminen K.R. Corticotropin-releasing hormone in amniotic fluid during gestation and labor and in relation to fetal lung maturation. Am J Obstet Gynecol 159 (1988) 891-895
32. Boddy K., Jones C.T., Mantell C., Ratcliffe J.G., and Robinson J.S. Changes in plasma ACTH and corticosteroid of the maternal and fetal sheep during hypoxia. Endocrinology 94 (1974) 588-591
33. Kulovich M.V., and Gluck L. The lung profile. II. Complicated pregnancy. Am J Obstet Gynecol 135 (1979) 64-70
34. Gross T.L., Sokol R.J., Wilson M.V., Kuhnert P.M., and Hirsch V. Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine growth retardation. Am J Obstet Gynecol 140 (1981) 277-281
35. Kitterman J.A., Liggins G.C., Campos G.A., Clements J.A., Forster C.S., Lee C.H., et al. Prepartum maturation of the lung in fetal sheep: relation to cortisol. J Appl Physiol 51 (1981) 384-390
36. Anderson A. Pre-term labour. Proceedings of the Fifth Study Group of the Royal College of Obstetricians and Gynecologists (5-10-1977) 273-280
37. Elimian A., Verma U., Canterino J., Shah J., Visintainer P., and Tejani N. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol 93 (1999) 174-179
38. Ley D., Wide-Swensson D., Lindroth M., Svenningsen N., and Marsal K. Respiratory distress syndrome in infants with impaired intrauterine growth. Acta Paediatr 86 (1997) 1090-1096
39. Jobe A.H., Wada N., Berry L.M., Ikegami M., and Ervin M.G. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 178 (1998) 880-885
40. Dunlop S.A., Archer M.A., Quinlivan J.A., Beazley L.D., and Newnham J.P. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med 6 (1997) 309-313
41. Aghajafari F., Murphy K., Matthews S., Ohlsson A., Amankwah K., and Hannah M. Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol 186 (2002) 843-849
42. Uno H., Lohmiller L., Thieme C., Kemnitz J.W., Engle M.J., Roecker E.B., et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 53 (1990) 157-167
43. French N.P., Hagan R., Evans S.F., Mullan A., and Newnham J.P. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 190 (2004) 588-595
44. Tyson J.E., Kennedy K., Broyles S., and Rosenfeld C.R. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival?. Pediatrics 95 (1995) 534-538
45. Bernstein I.M., Horbar J.D., Badger G.J., Ohlsson A., and Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 182 (2000) 198-206
46. Bamberg C., and Kalache K.D. Prenatal diagnosis of fetal growth restriction. Semin Fetal Neonatal Med 9 (2004) 387-394
47. Mamelle N., Boniol M., Riviere O., Joly M.O., Mellier G., Maria B., et al. Identification of newborns with Fetal Growth Restriction (FGR) in weight and/or length based on constitutional growth potential. Eur J Pediatr 165 (2006) 717-725
48. Burke G., Stuart B., Crowley P., Scanaill S.N., and Drumm J. Is intrauterine growth retardation with normal umbilical artery blood flow a benign condition?. BMJ 300 (1990) 1044-1045
49. Soothill P.W., Bobrow C.S., and Holmes R. Small for gestational age is not a diagnosis. Ultrasound Obstet Gynecol 13 (1999) 225-228
50. Craigo S.D., Beach M.L., Harvey-Wilkes K.B., and D'Alton M.E. Ultrasound predictors of neonatal outcome in intrauterine growth restriction. Am J Perinatol 13 (1996) 465-471
51. Abramovici D., Friedman S.A., Mercer B.M., Audibert F., Kao L., and Sibai B.M. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?. Am J Obstet Gynecol 180 (1999) 221-225
52. Brune T., Baytar-Dagly B., Hentschel R., Harms E., and Louwen F. Infants of mothers with HELLP syndrome compensate intrauterine growth retardation faster than unaffected premature infants: does HELLP change fetal programming?. Biol Neonate 82 (2002) 174-180